Pro-Life Caucus

HYDE-SMITH, ON 2ND ANNIV. OF DOBBS DECISION, SAYS VICTORY COMES WITH RESPONSIBILITY TO CONTINUE FIGHT FOR PRO-LIFE POLICIES

Hyde-Smith Issues Statement Saying Responsibility Also Includes Holding Pro-Abortion Administrations Accountable

WASHINGTON, D.C. – U.S. Senator Cindy Hyde-Smith (R-Miss.), chair of the Senate Pro-Life Caucus, today issued the following statement regarding the second anniversary of the historic June 24, 2022, U.S. Supreme Court decision in Dobbs v. Jackson Women’s Health...

HYDE-SMITH TAKES HEART, ABORTION PILL FIGHT WILL GO ON DESPITE DISAPPOINTING SCOTUS RULING

WASHINGTON, D.C. – U.S. Senator Cindy Hyde-Smith (R-Miss.), chair of the Senate Pro-Life Caucus, today issued the following statement after the U.S. Supreme Court ruling in U.S. Food and Drug Administration (FDA) v. Alliance for Hippocratic Medicine, which challenged FDA deregulation of chemical abortion drugs.  The court ruled that the plaintiffs lacked legal grounds to file the case, but did not rule on...

HYDE-SMITH SAYS FDA CAN’T DISMISS RAMIFICATIONS OF LAX CHEMICAL ABORTION DRUG REGS

At Hearing, Hyde-Smith Seeks FDA Response to Stockpiling of Chemical Abortion Drugs

 
VIDEO:  Senator Hyde-Smith Challenges Lax FDA Regulations on Access to Abortion Drugs.

WASHINGTON, D.C. – U.S. Senator Cindy Hyde-Smith (R-Miss.), chair of the Senate Pro-Life Caucus, today again challenged the lax standards set by the Food and Drug Administration (FDA) that permit access to chemical abortion drugs without...

HYDE-SMITH, PFLUGER LEAD BICAMERAL BRIEF TO SUPREME COURT CHALLENGING FDA DEREGULATION OF CHEMICAL ABORTION DRUGS

145 Lawmakers Argue FDA Violated Law, Endangered Women with 2016 &2021 Deregulation of Abortion-Inducing Drugs

WASHINGTON, D.C. – U.S. Senator Cindy Hyde-Smith (R-Miss.) and U.S. Representative August Pfluger (R-Texas-11) today led the filing a friend-of-the-court brief in a case before the U.S. Supreme Court that challenges the federal government’s deregulation of chemical...